Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia
Clinical trial NCT02453893 · UNKNOWN
Trial details
- NCT number
- NCT02453893
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-06-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.